No (%) of facilities reporting medicine ‘not available today’* | |||||
HIC 2 | HIC 1 | UMC | LMC | LIC | |
Total no of facilities | n=14 | n=5 | n=15 | n=16 | n=8 |
SIOP core | |||||
Asparaginase injection | 4/13 (31) | 0/5 | 4/15 (27) | 1/13 (8) | 0/7 |
Bleomycin injection | 2/13 (15) | 0/5 | 3/15 (20) | 4/14 (29) | 0/7 |
Carboplatin injection | 1/14 (7) | 0/5 | 1/15 (7) | 2/13 (15) | 1/7 (14) |
Cisplatin injection | 1/14 (7) | 0/5 | 1/15 (7) | 3/13 (23) | 0/6 |
Cyclophosphamide tablet | 1/12 (8) | 0/3 | 4/12 (33) | 4/9 (44) | 1/6 (17) |
Cyclophosphamide injection | 1/14 (7) | 0/5 | 2/15 (13) | 1/13 (8) | 0/7 |
Cytarabine injection | 1/14 (7) | 0/5 | 0/15 | 4/13 (31) | 1/7 (14) |
Dacarbazine injection | 1/12 (8) | 0/5 | 3/15 (20) | 4/9 (44) | 0/6 |
Dactinomycin injection | 1/14 (7) | 0/5 | 2/15 (13) | 2/12 (17) | 1/7 (14) |
Daunorubicin injection | 1/14 (7) | 0/5 | 2/13 (15) | 7/11 (64) | 1/5 (20) |
Doxorubicin injection | 1/14 (7) | 0/5 | 1/15 (7) | 3/13 (23) | 0/7 |
Etoposide capsule | 2/12 (17) | 0/2 | 5/10 (50) | 4/5 (80) | 1/3 (33) |
Etoposide injection | 1/14 (7) | 0/5 | 1/15 (7) | 2/14 (14) | 0/7 |
Hydroxycarbamide tablet/capsule | 0/10 | 0/3 | 3/10 (30) | 0/7 | 0/3 |
Ifosfamide injection | 1/14 (7) | 0/5 | 1/15 (7) | 3/12 (25) | 1/4 (25) |
Mercaptopurine tablet | 0/14 | 0/5 | 2/14 (14) | 3/14 (21) | 1/7 (14) |
Methotrexate tablet | 0/14 | 0/5 | 3/13 (23) | 4/13 (31) | 0/7 |
Methotrexate injection | 0/14 | 0/5 | 1/15 (7) | 2/14 (14) | 0/7 |
Thioguanine tablet | 1/11 (9) | 0/4 | 3/11 (27) | 4/5 (80) | 0/1 |
Vinblastine injection | 1/14 (7) | 0/5 | 3/15 (20) | 4/11 (36) | 1/6 (17) |
Vincristine injection | 1/14 (7) | 0/5 | 2/15 (13) | 3/14 (21) | 1/7 (14) |
SIOP ancillary | |||||
13-cis retinoic acid tablet/capsule | 2/12 (17) | 0/4 | 4/11 (36) | 3/5 (60) | 0/1 |
All-trans retinoic acid capsule | 2/13 (15) | 0/4 | 4/13 (31) | 3/8 (38) | 2/4 (50) |
Busulphan tablet | 2/5 (40) | 0/2 | 5/9 (56) | 1/3 (33) | |
Imatinib tablet | 1/14 (7) | 0/5 | 4/15 (27) | 4/10 (40) | 1/6 (17) |
Irinotecan injection | 1/14 (7) | 1/5 (20) | 3/14 (21) | 2/5 (40) | 0/2 |
Melphalan tablet | 1/6 (17) | 0/2 | 2/7 (29) | 2/5 (40) | 1/2 (50) |
Topotecan injection | 1/14 (7) | 0/5 | 3/12 (25) | 3/5 (60) | 0/1 |
Vinorelbine injection | 2/14 (14) | 0/3 | 2/13 (15) | 3/6 (50) | 0/1 |
Other WHO EMLc | |||||
Calcium folinate (leucovorin) inject | 1/13 (8) | 0/5 | 2/15 (13) | 1/11 (9) | 0/7 |
Calcium folinate (leucovorin) tablet | 1/12 (8) | 0/4 | 4/13 (31) | 2/5 (40) | 1/5 (20) |
Filgrastim injection | 1/13 (8) | 0/5 | 1/15 (7) | 1/10 (10) | 0/4 |
Mesna tablet | 1/6 (17) | 0/3 | 3/6 (50) | ||
Mesna injection | 1/14 (7) | 0/5 | 1/15 (7) | 4/13 (31) | 0/4 |
*Only facilities reporting that the medicine is used are included in the denominator for calculation of %.
EMLc, Essential Medicines for Children; HIC, high-income country; LIC, low-income country; LMC, lower-middle-income country; SIOP, International Society of Paediatric Oncology ; UMC, upper-middle-income country.